tHEORetically Speaking - Randomized Control Trials Archives

How Should a Safe and Effective COVID‑19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton

C T2023-11-15T12:40:33-05:00September 28th, 2020|Categories: Blog|Tags: Coronavirus, Cost Effectiveness Analysis, COVID-19, health economics, Randomized Control Trials, tHEORetically Speaking, Vaccine|

Recently, there have been encouraging commitments around the world to manufacture coronavirus disease 2019 (COVID-19) vaccines in anticipation of results from clinical studies.

Advancing Real-World Evidence with Pragmatic Clinical Trials: Interview with Dr. Joseph Singer, Chief Medical Officer of HealthCore-NERI

C T2023-11-15T17:41:24-05:00January 21st, 2019|Categories: Blog|Tags: clinical trials, PCT, Pragmatic Clinical Trials, Randomized Control Trials, RCT, real world evidence, RWE, tHEORetically Speaking|

Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Joseph Singer, CMO of HealthCore-NERI, to discuss how pragmatic clinical [...]

Randomized Control Trials

Receive essential insights, resources and content direct to your inbox!

Latest News

FDA Approves Groundbreaking CRISPR Gene-Editing Medicine for Sickle Cell Disease

December 8, 2023

Advancements and Challenges in GLP-1 Based Therapies for Diabetes and Obesity

Implementing Diversity Action Plans in Clinical Trials: Navigating FDA Requirements and Enhancing Inclusivity

December 7, 2023

Featured Webinars

Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters

Tuesday, December 5, 2023

Sponsor: ICON

EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025

Friday, November 10, 2023

Sponsor: OpenHealth

Cell & Gene Therapies – Beginning with the End in Mind

Thursday, November 2, 2023

Sponsor: Magnolia Market Access

Categories